Use of the extreme drug resistance assay to evaluate mechanisms of resistance in ovarian cancer: taxol resistance and MDR-1 expression.

Source:http://linkedlifedata.com/resource/pubmed/id/7995052

Download in:

View as

General Info

PMID
7995052